Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.
A new startup founded by a former Google DeepMind scientist is exiting stealth with $50 million in funding. Latent Labs is ...
The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics ...
As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...
Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...
Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...
The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...
Former DeepMind scientist Simon Kohl has raised $50 million for Latent Labs, a London-based AI startup aiming to transform ...
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
The fundraising was co-led by Radical Ventures, which specialises in AI software companies, and European healthcare venture firm Sofinnova Partners. Other investors include Jeff Dean, Google’s chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback